文献速递皮肤肿瘤

手术再切除与观察治疗组织学异型痣的临床结局系统综述

Surgical re-excision vs. observation for histologically dysplastic naevi: a systematic review of associated clinical outcomes.
PubMed 文献 · Br J Dermatol · 2018-06-21

系统综述评估活检证实的组织学异型痣(HDN)在再切除或观察后活检部位原发性黑色素瘤的发生率。共纳入12项研究、2673个HDN,观察组1535个、再切除组1138个。观察组活检部位黑色素瘤发生率0.39%,再切除组0.44%,发生率均低。作者认为HDN可观察,但纳入文献质量低,需进一步前瞻性试验。

要点

  • 观察组活检部位黑色素瘤发生率0.39%,再切除组0.44%,两组均低。
  • 12项研究中9项报告无黑色素瘤发生,3项共报告11例活检部位黑色素瘤。
  • 所有纳入文献质量低,作者认为需进一步前瞻性试验指导临床决策。

核心结论

  • 基于现有证据,观察组和再切除组活检部位原发性黑色素瘤发生率均低。
  • 作者认为HDN可观察,黑色素瘤相关不良结局极少,但所有纳入文献质量低,进一步前瞻性试验可更好指导临床决策。

研究设计与样本

  • 系统综述,共筛选5293条记录,18篇全文评估,12项研究符合纳入标准,未发现对照试验。
  • 12项研究中11项(92%)为回顾性病历回顾,1项为横断面和队列研究;9项(75%)无头对头比较组。
  • 共纳入2673个不同级别的HDN,其中观察组1535个,再切除组1138个;随访时间2周至30年。

主要发现

  • 9项研究报告无黑色素瘤发生。
  • 3项研究共报告11例活检部位黑色素瘤,观察组6例(0.39%),再切除组5例(0.44%)。

局限性

  • 所有纳入文献质量低。
  • 多数研究(11/12,92%)为回顾性病历回顾。
  • 许多研究(9/12,75%)无头对头比较组,仅报告再切除或观察的HDN。
  • 作者认为需进一步前瞻性试验以更好指导临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The management of histologically dysplastic naevi (HDN) with re-excision vs. observation remains controversial because of lack of evidence about associated melanoma outcomes. OBJECTIVES: To assess published data on the development of biopsy-site primary cutaneous melanoma among biopsy-proven HDN managed with either re-excision or observation. METHODS: A systematic review of all published data: a total of 5293 records were screened, 18 articles were assessed in full text and 12 studies met inclusion criteria. No controlled trials were identified. RESULTS: Most studies (11 of 12, 92%) were retrospective chart reviews, and one was both a cross-sectional and cohort study. Many studies (nine of 12, 75%) had no head-to-head comparison groups and either only reported HDN that were re-excised or observed. A total of 2673 (1535 observed vs. 1138 re-excised) HDN of various grades were included. Follow-up varied between 2 weeks and 30 years. Nine studies reported that no melanomas developed. Eleven biopsy-site melanomas developed across three of the studies, six among observed lesions (0·39%) and five among re-excised lesions (0·44%). CONCLUSIONS: Based upon the available evidence the rates of biopsy-site primary melanoma were similarly low among observed lesions and re-excised lesions. This suggests that HDNs can be observed with minimal adverse melanoma-associated outcomes. However, all included articles were of low quality and further prospective trials could better guide clinical decision making.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Vuong KT, Walker J, Powell HB, et al. Surgical re-excision vs. observation for histologically dysplastic naevi: a systematic review of associated clinical outcomes. Br J Dermatol. 2018. PMID: 29570779. doi:10.1111/bjd.16557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。